ALFA Finder| Revenue growth | FY26 Total Income grew ~25.6% YoY vs FY25. |
|---|---|
| Margins | EBITDA margin showed structural improvement in FY26. |
| Demand visibility | Strong growth in specialty segments like electronics and green chemicals. |
| Management confidence | High, focusing on process-driven organization and structured succession planning. |
Growth
FY26 Total Income reached ₹24,365.03 Lakhs, with EBITDA at ₹1,636.58 Lakhs and Net Profit recovering to ₹133.43 Lakhs.
Outlook
Expanding Tarapur facility to double capacity; scaling Salicylic Acid to ~200 T/month and Acrylics to ~4,500 T/month.
Risks
Global supply chain resilience and limited availability of certain raw materials are primary concerns for specialized molecules.
Investor Presentation filed with NSE, NSE: AMBANIORGO. Summary written with AI assistance from the document.
Ambani Orgochem Ltd: key numbers
- Share price
- ₹180.65
- Market cap
- ₹136.2 Cr
- Revenue (annual)
- ₹240.7 Cr
- Net profit (annual)
- ₹1.33 Cr
- P/E (TTM)
- 102.1×Sector 35.5×
- Promoter holding
- 52.59%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ambani Orgochem Ltd
All →Ambani Orgochem Credit Rating
Infomerics upgraded Ambani Orgochem's bank loan ratings to IVR BBB-/Stable and removed them from Issuer Not Cooperating. The action reflects improved financial risk profile.
Ambani Orgochem Earnings Call Transcript: Key Takeaways
H1 FY27 consolidated revenue +54.87% to ₹171.22 Cr; PAT ₹3.45 Cr from ₹0.19 Cr. EBITDA +43% but margin slipped; management gives no numeric guidance.
Ambani Orgochem Management Change
Ambani Orgochem announced the resignation of non-executive non-independent director Bhavin Patel, effective 29 October 2026. The resignation was attributed to professional priorities and commitments.
Ambani Orgochem Convertible Warrants
Ambani Orgochem members approved a Rs 43.93 Crore preferential warrant issue and capital changes. Promoters receive 30.1 lakh of the 43.93 lakh warrants.
- Value
- ₹43.93 Cr
Ambani Orgochem Investor Presentation: Key Takeaways
H1 FY27 consolidated: revenue ₹171.22 cr (+54.87%), EBITDA ₹11.32 cr (+43.00%), PAT ₹3.45 cr vs ₹0.19 cr. Strategy: capacity expansion and downstream specialty chemicals.
Ambani Orgochem Annual General Meeting
Ambani Orgochem's 1st EGM on 26 October 2026 took up four special resolutions. Items cover authorised capital, the capital clause, and preferential warrants.